Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01897116
Title A Phase I Trial of Vemurafenib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications

melanoma

Therapies

Hydroxychloroquine + Vemurafenib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST